Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2022 | 02-2022 | 11-2021 | 08-2021 | 05-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,934 | -42,533 | -117,194 | -79,492 | -50,657 |
| Depreciation Amortization | 5,878 | 2,795 | 7,788 | 5,572 | 3,430 |
| Accounts receivable | 6,000 | N/A | -6,000 | 0 | -2,537 |
| Accounts payable and accrued liabilities | 1,747 | -103 | 1,589 | 727 | 2,119 |
| Other Working Capital | -6,544 | -8,963 | 9,113 | 9,381 | 17,101 |
| Other Operating Activity | 5,309 | 6,174 | 20,339 | 10,358 | 7,062 |
| Operating Cash Flow | $-75,544 | $-42,630 | $-84,365 | $-53,454 | $-23,482 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,261 | -3,472 | -5,661 | -4,799 | -2,934 |
| Purchase Of Investment | -80,031 | -15,245 | -348,497 | -257,813 | -183,238 |
| Sale Of Investment | 121,558 | 58,748 | 245,907 | 190,884 | 126,675 |
| Investing Cash Flow | $35,266 | $40,031 | $-108,251 | $-71,728 | $-59,497 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,920 | 1,488 | 153,883 | 153,383 | 151,831 |
| Common Stock Repurchased | N/A | N/A | -1 | -1 | -1 |
| Financing Cash Flow | $1,920 | $1,488 | $153,882 | $153,382 | $151,830 |
| Beginning Cash Position | 80,792 | 80,792 | 119,526 | 119,526 | 119,526 |
| End Cash Position | 42,434 | 79,681 | 80,792 | 147,726 | 188,377 |
| Net Cash Flow | $-38,358 | $-1,111 | $-38,734 | $28,200 | $68,851 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,544 | -42,630 | -84,365 | -53,454 | -23,482 |
| Capital Expenditure | -6,261 | -3,472 | -5,661 | -4,799 | -2,934 |
| Free Cash Flow | -81,805 | -46,102 | -90,026 | -58,253 | -26,416 |